Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV inï¿½vitro and inï¿½vivo-Reference-Cited by-同舟云学术

Engineered zinc-finger transcription factors inhibit the replication and transcription of HBV inï¿½vitro and inï¿½vivo

Published:2018-01-17 Issue: Volume: Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Luo Wei¹,Wang Junxia²,Xu Dengfeng³,Bai Huili⁴,Zhang Yangli⁴,Zhang Yuhong⁴,Li Xiaosong⁴

Affiliation:

1. Department of General Surgery, The Second Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

2. Department of Neonatology, The Second Affiliated Hospital, Southwest Medical University, Luzhou, Sichuan 646000, P.R. China

3. Department of Ophthalmology, Chongqing General Hospital, Chongqing 400014, P.R. China

4. Department of Molecular Diagnostics, Center for Clinical Molecular Medical Detection, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, P.R. China

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Solamargine acts as an antiviral by interacting to MZF1 and targeting the core promoter of the hepatitis B virus gene;Aging;2024-08-10

2. Epigenome editing technologies for discovery and medicine;Nature Biotechnology;2024-07-29

3. Gene-Editing and RNA Interference in Treating Hepatitis B: A Review;Viruses;2023-12-08

4. Chromosome hyperploidy induced by chronic hepatitis B virus infection and its targeted therapeutic strategy;World Chinese Journal of Digestology;2023-04-28

5. Advances in determining new treatments for hepatitis B infection by utilizing existing and novel biomarkers;Expert Opinion on Drug Discovery;2023-03-21